Neuronal Vulnerability to Proteinopathies in Alzheimers Disease and Alzheimers Disease-Related Dementias (R01 Clinical Trial Not Allowed)
National Institutes of Health
Posted on:
Type
Research/project funding
Funding Opportunity RFA-AG-23-028 from the NIH Guide for Grants and Contracts. The goal of this Funding Opportunity Announcement (FOA) is to define and characterize neuronal and glial cell populations that are vulnerable to Alzheimer's disease (AD) and AD-related dementias (ADRD) proteinopathies.